Trials / Completed
CompletedNCT02824172
Treatment of the Osgood Schlatter
Treatment of the Osgood Schlatter Disease by Immobilization ( Ankle Cruro Resin ) Versus Sporting Rest ( Reference Treatment ) : Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 9 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
The disease Osgood-Schlatter is most commonly found in sports teenager growing up apophysose accounting for 28.4% of osteochondrosis by Breck. It relates to 62% of osteochondrosis knee and affects adolescent girls between 10 and 12 and boys between 12 and 15 It is usually considered a benign pathology that cures in the majority of cases. However, in 5-10% of cases there is persistent residual pain in adulthood. The classic complication is the avulsion fracture of the tibial tuberosity in adolescents who continued his sports without restriction. The possible consequences are numerous including the presence of a free bone fragment at the insertion of the tendon originally described by Osgood the establishment of a genu recurvatum, a high kneecap or patella alta and an enlarged tibial tuberosity (ATT) annoying sport. The main two treatments are complete rest from sport activity or cast immobilization. The main objective is to compare these two technics according to the proportion of full sporting recovering at 12 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cast immobilization group | Patients in this group will have their knee locked with a resin going from the ankle to the top of the thigh for 4 weeks, followed by 4 weeks without cast but with rehabilitation through physiotherapy. |
| OTHER | complete sport rest. | Patients included in this group will follow the current standard procedure for this disease that is to say complete sport rest during 8 weeks including rehabilitation through physiotherapy, following the exact same technic as the experimental group . |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-07-06
- Last updated
- 2025-12-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02824172. Inclusion in this directory is not an endorsement.